Nine months after reports of a security review by U.S./UK investment screening officials, the acquisition by a company with Chinese links of a U.S./UK pharmaceutical company has been approved by both governments.

Last week, the Office of the United States Trade Representative (USTR) submitted to Congress its Budget Justification for Fiscal Year 2024, with China trade issues playing an important role in the document.

This past week, CTM covered the following issues. In China: * New trade data * Two Sessions work reports * China-Belarus meeting and agreements In the U.S.: * U.S-Lithuania meeting discusses China issues * Export licensing data released and new sanctions on Chinese firms * Congressional action on Hikvision sanctions, Chinese IP

A House of Representatives Subcommittee held a hearing yesterday on "Intellectual Property and Strategic Competition with China," with members of the Subcommittee and expert witnesses discussing a number of issues related to Chinese intellectual property protection, including the patent system and innovation in China.

The two leaders of the House Foreign Affairs Committee have requested that President Biden make a determination about whether sanctions should be imposed on Hangzhou Hikvision Digital Technology Co., Ltd. (Hikvision) for its activities related to human rights abuses.

This week, Lithuanian Minister of Foreign Affairs Gabrielius Landsbergis was in Washington, D.C. to meet with several Biden administration officials, and relations with China were a main focus.

In late February, a bipartisan group of members of the U.S. House of Representatives introduced legislation that would "limit foreign adversaries like China from accessing goods and technologies capable of supporting undersea cables and establishing agreements with allies and partners to do the same." That bill has